Jacqueline Knufer
Koeln, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Preclinical assessment of broadly neutralizing HIV-1 antibody BNT351 with optimized pharmacokinetics and potent antiviral activity.
Journal: iScience
Published: March 10, 2026
Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitope.
Journal: bioRxiv : the preprint server for biology
Published: September 18, 2025
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy.
Journal: bioRxiv : the preprint server for biology
Published: September 05, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy.
Journal: Nature immunology
Published: March 06, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy.
Journal: Nature immunology
Published: March 06, 2025
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients.
Journal: Nature communications
Published: December 22, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies.
Journal: Blood cancer discovery
Published: January 20, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026